VIEMED HEALTHCARE, INC. Research and Development Expense
VIEMED HEALTHCARE, INC. (VMD) reported Research and Development Expense of $504.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. research and development expense for the quarter ending 2026-06-30 was $504.00K, a 40.50% decline year-over-year.
- VIEMED HEALTHCARE, INC. research and development expense for the quarter ending 2026-03-31 was $579.00K, a 27.35% decline year-over-year.
- VIEMED HEALTHCARE, INC. research and development expense for the quarter ending 2025-12-31 was $598.00K, a 25.53% decline year-over-year.
- VIEMED HEALTHCARE, INC. research and development expense for the quarter ending 2025-09-30 was $775.00K, a 2.38% increase year-over-year.
- VIEMED HEALTHCARE, INC. research and development expense for fiscal 2025 was $3.02M, a 1.66% decline from fiscal 2024.
- VIEMED HEALTHCARE, INC. research and development expense for fiscal 2024 was $3.07M, a 10.28% increase from fiscal 2023.
- VIEMED HEALTHCARE, INC. research and development expense for fiscal 2023 was $2.78M, a 3.19% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. research and development expense for fiscal 2022 was $2.70M, a 27.77% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $504.00K 10-Q · filed 2026-08-03 | $1.08M 10-Q · filed 2026-08-03 | $1.68M derived: sum of 3 quarters · filed 2026-08-03 | $2.46M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $579.00K 10-Q · filed 2026-05-05 | $1.18M derived: sum of 2 quarters · filed 2026-05-05 | $1.95M derived: sum of 3 quarters · filed 2026-05-05 | $2.80M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $1.37M derived: sum of 2 quarters · filed 2026-03-04 | $2.22M derived: sum of 3 quarters · filed 2026-08-03 | $3.02M 10-K · filed 2026-03-04 |
| 2025-09-30 | $775.00K 10-Q · filed 2025-11-05 | $1.62M derived: sum of 2 quarters · filed 2026-08-03 | $2.42M 10-Q · filed 2025-11-05 | $3.22M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $847.00K 10-Q · filed 2026-08-03 | $1.64M 10-Q · filed 2026-08-03 | $2.45M derived: sum of 3 quarters · filed 2026-08-03 | $3.20M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $797.00K 10-Q · filed 2026-05-05 | $1.60M derived: sum of 2 quarters · filed 2026-05-05 | $2.36M derived: sum of 3 quarters · filed 2026-05-05 | $3.12M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $803.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $1.56M derived: sum of 2 quarters · filed 2026-03-04 | $2.32M derived: sum of 3 quarters · filed 2026-03-04 | $3.07M 10-K · filed 2026-03-04 |
| 2024-09-30 | $757.00K 10-Q · filed 2025-11-05 | $1.51M derived: sum of 2 quarters · filed 2025-11-05 | $2.27M 10-Q · filed 2025-11-05 | $2.92M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | $758.00K 10-Q · filed 2025-08-06 | $1.51M 10-Q · filed 2025-08-06 | $2.16M derived: sum of 3 quarters · filed 2026-03-04 | $2.75M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | $750.00K 10-Q · filed 2025-05-07 | $1.40M derived: sum of 2 quarters · filed 2026-03-04 | $1.99M derived: sum of 3 quarters · filed 2026-03-04 | $2.75M derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | $651.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $1.24M derived: sum of 2 quarters · filed 2026-03-04 | $2.00M derived: sum of 3 quarters · filed 2026-03-04 | $2.78M 10-K · filed 2026-03-04 |
| 2023-09-30 | $593.00K 10-Q · filed 2024-11-06 | $1.35M derived: sum of 2 quarters · filed 2024-11-06 | $2.13M 10-Q · filed 2024-11-06 | $2.85M derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-06-30 | $758.00K 10-Q · filed 2024-08-07 | $1.54M 10-Q · filed 2024-08-07 | $2.26M derived: sum of 3 quarters · filed 2025-03-10 | $2.93M derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-03-31 | $780.00K 10-Q · filed 2024-05-06 | $1.50M derived: sum of 2 quarters · filed 2025-03-10 | $2.17M derived: sum of 3 quarters · filed 2025-03-10 | $2.84M derived: sum of 4 quarters · filed 2025-03-10 |
| 2022-12-31 | $722.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $1.39M derived: sum of 2 quarters · filed 2025-03-10 | $2.06M derived: sum of 3 quarters · filed 2025-03-10 | $2.70M 10-K · filed 2025-03-10 |
| 2022-09-30 | $670.00K 10-Q · filed 2023-11-01 | $1.34M derived: sum of 2 quarters · filed 2023-11-01 | $1.97M 10-Q · filed 2023-11-01 | $2.59M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $672.00K 10-Q · filed 2023-08-09 | $1.30M 10-Q · filed 2023-08-09 | $1.92M derived: sum of 3 quarters · filed 2023-08-09 | $2.49M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $632.00K 10-Q · filed 2023-05-08 | $1.24M derived: sum of 2 quarters · filed 2023-05-08 | $1.82M derived: sum of 3 quarters · filed 2023-05-08 | $2.40M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.19M derived: sum of 2 quarters · filed 2023-03-02 | $1.77M derived: sum of 3 quarters · filed 2023-03-02 | $2.11M 10-K · filed 2023-03-02 |
| 2021-09-30 | $576.00K 10-Q · filed 2022-11-01 | $1.16M derived: sum of 2 quarters · filed 2022-11-01 | $1.50M 10-Q · filed 2022-11-01 | $1.89M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $583.00K 10-Q · filed 2022-08-02 | $922.00K 10-Q · filed 2022-08-02 | $1.32M derived: sum of 3 quarters · filed 2022-08-02 | $1.56M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $339.00K 10-Q · filed 2022-05-03 | $734.00K derived: sum of 2 quarters · filed 2022-05-03 | $977.00K derived: sum of 3 quarters · filed 2022-05-03 | $1.25M derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $395.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $638.00K derived: sum of 2 quarters · filed 2022-03-07 | $909.00K derived: sum of 3 quarters · filed 2022-03-07 | $1.08M 10-K · filed 2022-03-07 |
| 2020-09-30 | $243.00K 10-Q · filed 2021-11-02 | $514.00K derived: sum of 2 quarters · filed 2021-11-02 | $688.00K 10-Q · filed 2021-11-02 | $891.00K derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $271.00K 10-Q · filed 2021-08-03 | $445.00K 10-Q · filed 2021-08-03 | $648.00K derived: sum of 3 quarters · filed 2021-08-03 | $856.00K derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $174.00K 10-Q · filed 2021-05-03 | $377.00K derived: sum of 2 quarters · filed 2021-05-03 | $585.00K derived: sum of 3 quarters · filed 2021-05-03 | $788.00K derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $411.00K derived: sum of 2 quarters · filed 2021-03-03 | $614.00K derived: sum of 3 quarters · filed 2021-03-03 | $848.00K 10-K · filed 2021-03-03 |
| 2019-09-30 | $208.00K 10-Q · filed 2020-11-04 | $411.00K derived: sum of 2 quarters · filed 2020-11-04 | $645.00K 10-Q · filed 2020-11-04 | $645.00K derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | $203.00K 10-Q · filed 2020-08-04 | $437.00K 10-Q · filed 2020-08-04 | $437.00K derived: sum of 3 quarters · filed 2020-08-04 | $437.00K derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $234.00K 10-Q · filed 2020-05-05 | $234.00K derived: sum of 2 quarters · filed 2020-05-05 | $234.00K derived: sum of 3 quarters · filed 2020-05-05 | $234.00K derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-04 | $0.00 derived: sum of 2 quarters · filed 2020-03-04 | $0.00 derived: sum of 3 quarters · filed 2020-03-04 | $0.00 10-K · filed 2020-03-04 |
| 2018-09-30 | $0.00 10-K · filed 2020-03-04 | $0.00 derived: sum of 2 quarters · filed 2020-03-04 | $0.00 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $0.00 10-K · filed 2020-03-04 | $0.00 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $0.00 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |